Author

David Bachner

Institution: Merck Healthcare KGaA, Darmstadt (Germany)

Observed institutions: EMD Serono, Inc. (United States), Merck Healthcare KGaA, Darmstadt (Germany)

OpenAlex ID: A5082999862

Brain penetration and efficacy of tepotinib in orthotopic patient-derived xenograft models of MET-driven non-small cell lung cancer brain metastases

2021 · Manja Friese-Hamim, Anderson Clark, et al. · Lung Cancer · 27

Abstract 3407: Anti-tumor activity of tepotinib in orthotopic models of lung cancer patient-derived brain metastases with MET amplification

2020 · Manja Friese-Hamim, Anderson Clark, et al. · Cancer Research · 1

Works count: 2

Citation count: 28

H-index: 1

I10-index: 1